The Global Cold Pain Therapy Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2027.
Some of the prominent trends that the market is witnessing include growing adoption of analgesic patches and growing number of hip and knee surgeries.
By Application, market is categorized into Sports Medicine, Musculoskeletal Disorders, Post-Trauma Therapy and Post-Operative Therapy, Dermatology, Oncology, Ophthalmology, Pain Management and Physical therapy.
By Product, market is divided into Prescription Products and OTC Products. In addition, Prescription Products segment is fragmented into Motorized Devices and Non-Motorized Devices. OTC Products segment is segregated into Medical Devices and Pharmaceuticals. Moreover, Medical Devices is segmented into Cooling Towels, Compresses, Wraps, & Pads and Cold Packs. Pharmaceuticals are segregated into Roll-Ons, Sprays and Foams, Gels, Ointments, and Creams and Patches.
On the basis of Therapy Type, market is classified into Icepack Therapy, Chamber Therapy and Cryosurgery.
By Device Type, market is divided into Dipstick applicator, Cryoprobe, Spray Cryogen and other Device Types.
Based on Distribution Channel, market is divided into Hospital Pharmacies, Online Pharmacies and Retail Pharmacies.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
This report provides data tables, includes charts and graphs for visual analysis.
Regional Analysis: North America - US - Canada - Mexico
Europe - France - Germany - Italy - Spain - UK - Rest of Europe
Asia Pacific - China - Japan - India - Australia - New Zealand - Rest of Asia Pacific
Middle East - Saudi Arabia - UAE - Rest of Middle East
Latin America - Argentina - Brazil - Rest of Latin America
Rest of the World - South Africa - Others
Report Highlights: - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2027, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2027 - Market opportunities and recommendations for new investments
Our reports have been used by over 10K customers, including:
2019 US Drugs of Abuse Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers This new 262-page report provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, Technologies, instrumentation,...
215 pages •
By Asia Market Information & Development Company
• Apr 2019
China’s demand for OTC Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
2019-2023 Europe Drugs of Abuse Testing Market: France, Germany, Italy, Spain, UK--Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers This new 300-page report from VPGMarketResearch provides a comprehensive analysis...
2019-2023 US Drugs of Abuse Testing Market: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers This new 262-page report provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies,...
Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 220.127.116.11) - Pipeline Review, H1 2019 Summary Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type...
Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Pipeline Review, H1 2019 Summary According to the recently published report ’Retinoic Acid Receptor Gamma - Pipeline Review, H1 2019’; Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor...
Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019 Summary Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Metabotropic glutamate receptor 2 is a protein encoded by the GRM2 gene. It is a receptor for glutamate. Ligand binding causes a conformation change that triggers signaling...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.